Neuphoria Therapeutics
NEUP
3 hedge funds and large institutions have $687K invested in Neuphoria Therapeutics in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
25% less funds holding
Funds holding: 4 → 3 (-1)
58% less capital invested
Capital invested by funds: $1.62M → $687K (-$937K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$298K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Point72 Asset Management
Stamford,
Connecticut
| $333K | – | – | – |
|
|
BI
2
BVF Inc
San Francisco,
California
| $211K | – | – | – |
|
|
WP
3
Woodline Partners
San Francisco,
California
| $143K | -$298K | -7,065 | -61% |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$4.05K | -73 | Closed |
|
NEUP Hedge Fund Activity: Q1 2023 in Review
3 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Neuphoria Therapeutics (NEUP) for Q1 2023, worth a combined $687K — down 58% from $1.62M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NEUP and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Woodline Partners, cutting an estimated $298K.
- 3 institutional investors held Neuphoria Therapeutics (NEUP) as of Q1 2023, down from 4 in Q4 2022.
- Funds reported $687K of Neuphoria Therapeutics stock for Q1 2023, down 58% quarter-over-quarter.
- 0 funds opened new Neuphoria Therapeutics positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest Neuphoria Therapeutics seller in Q1 2023 was Woodline Partners, an estimated $298K sold.
Based on aggregated 13F filings for Q1 2023.